China Hemodialysis and Peritoneal Dialysis Market Size - Share Outlook, Growth Analysis Report and Forecast Trends (2026-2035)

China Hemodialysis and Peritoneal Dialysis Market Overview

Hemodialysis assists individuals with impaired kidney function by routing blood through an external system for purification, whereas peritoneal dialysis uses the peritoneal membrane to facilitate internal fluid and toxin exchange, offering more independence. The market is poised to grow at a CAGR of 9.30% during the forecast period of 2026-2035, driven by rising end-stage renal disease prevalence, wider acceptance of home-based therapies, and sustained healthcare investments. These factors collectively enhance service capacity, support technological improvements, and strengthen access to advanced dialysis solutions across the region.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

China Hemodialysis and Peritoneal Dialysis Market Growth Drivers

Rising Chronic Kidney Disease Prevalence to Fuel the Market Demand

The increasing prevalence of chronic kidney disease (CKD) in China is a key growth driver for the hemodialysis and peritoneal dialysis market. According to et al., 2025, approximately 82 million adults in China are affected by CKD, often accompanied by poorly controlled comorbidities such as hypertension, diabetes, and dyslipidemia. The substantial patient pool has driven higher demand for both hemodialysis and peritoneal dialysis therapies, as healthcare providers expand access and treatment options. This rising patient burden is expected to contribute significantly to the sustained growth of the Chinese dialysis market in the coming years.

China Hemodialysis and Peritoneal Dialysis Market Trends

The market is experiencing key trends such as strategic consolidation and the increasing adoption of hemodialysis and peritoneal dialysis.

Strategic Consolidation is Poised to Accelerate the Market Value

The market is witnessing a strategic consolidation trend, driven by mergers, acquisitions, and portfolio optimization among key players. In October 2024, Fresenius Medical Care AG completed the divestment of six hospital centers in China, transferring ownership to Jiangxi Dakang Medical Management Co., Ltd., a leading provider of hemodialysis services with over 70 centers nationwide. This strategic realignment reflects industry efforts to enhance operational efficiency and expand patient access to specialized renal care. Such consolidations are expected to strengthen market infrastructure and fuel sustained growth in China’s dialysis sector.

Rising Hemodialysis and Peritoneal Dialysis Adoption to Boost the China Hemodialysis and Peritoneal Dialysis Market Expansion

The market is experiencing significant growth due to the rising prevalence of chronic kidney disease and increasing patient demand for renal replacement therapies. According to Wendi Cheng et al., 2025, China has the largest global population of maintenance hemodialysis patients. During the 2024 Academic Annual Meeting of the Chinese Nephrology Association in January 2024, academician Xiangmei Chen revealed that by December 2023, the country had 7,512 hemodialysis centers catering to 916,600 patients, reflecting a prevalence rate of 635 per million population. This trend underscores sustained market growth and expanding opportunities for dialysis providers.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

China Hemodialysis and Peritoneal Dialysis Market Segmentation

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

China Hemodialysis and Peritoneal Dialysis Market Share

Hemodialysis Segment Poised to Dominate Market Share by Type

The market is segmented by type into peritoneal dialysis and hemodialysis. Among these, hemodialysis is expected to lead the market, holding the largest revenue share of around 80% in the historical period. The dominance of this segment is driven by its widespread adoption in healthcare facilities, the growing prevalence of chronic kidney disease, and increasing preference for in-center treatments among patients. Strong clinical infrastructure and availability of advanced hemodialysis machines further support its market leadership. With these factors, Hemodialysis is projected to continue its robust growth, maintaining its leading position in the coming years.

Leading Players in the China Hemodialysis and Peritoneal Dialysis Market

Other key players in the market are B. Braun SE, Beijing Yian Medical Systems Co., Ltd., Chengdu Wesley Bioscience Technology Co., Ltd., Shenzhen Mindray, Nipro Corporation, and Becton, Dickinson and Company.

Key Questions Answered in the China Hemodialysis and Peritoneal Dialysis Market

• What was the China hemodialysis and peritoneal dialysis market value in 2025?
• What is the China hemodialysis and peritoneal dialysis market forecast outlook for 2026-2035?
• What major factors aid the demand for the China hemodialysis and peritoneal dialysis market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major China hemodialysis and peritoneal dialysis market trends?
• Which product is expected to dominate the market segment?
• Which type is projected to lead the market segment?
• Which indications are anticipated to drive the market segment?
• Which end use is likely to dominate the market segment?
• Who are the key players in the China hemodialysis and peritoneal dialysis market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?